14.5 C
New York
Monday, May 19, 2025
Home Blog

Ancient fossil found in Canada reveals moth-like predator with three eyes

0

Paleontologists recently discovered a 506-million-year-old “moth-like” predator that lurked in prehistoric Canada.

In a press release from the Royal Ontario Museum (ROM), officials identified the creature as Mosura fentoni, an extinct anthropoid, as news agencies including SWNS reported. (See the video at the top of this article.) 

The museum reported that most of the Mosura fossils were collected by ROM paleontologists at Raymond Quarry in Yoho National Park in British Columbia. 

‘WELL-PRESERVED’ BABY MAMMOTH DATING BACK TO ICE AGE DISSECTED BY SCIENTISTS: PHOTOS

Most were found between 1975 and 2022.

“Mosura fentoni was about the size of your index finger and had three eyes, spiny jointed claws, a circular mouth lined with teeth and a body with swimming flaps along its sides,” the museum noted. 

Mosura fentoni was an extinct anthropod that lived 506 million years ago, according to experts. (Royal Ontario Museum)

“These traits show it to be part of an extinct group known as the radiodonts, which also included the famous Anomalocaris canadensis, a meter-long predator that shared the waters with Mosura.”

What makes the discovery so interesting to researchers is that Mosura had an abdomen-like body region made up of multiple segments at its back end – which had not been previously observed in any radiodonts.

ANCIENT SETTLEMENT REVEALS REMAINS OF 1,800-YEAR-OLD DOG, BAFFLING EXPERTS: ‘PRESERVED QUITE WELL’

Joe Moysiuk, a curator of paleontology and geology at the Manitoba Museum, said Mosura had 16 of these segments, all lined with gills.

“This is a neat example of evolutionary convergence with modern groups, like horseshoe crabs, woodlice and insects, which share a batch of segments bearing respiratory organs at the rear of the body,” Moysiuk described.

Ancient fossil of predator

Fossils show the details of Mosura’s internal anatomy – including its nervous system and digestive tract. (Royal Ontario Museum)

The museum reported that the species has been nicknamed the “sea-moth” by field collectors based on its moth-like attributes.

For more Lifestyle articles, visit foxnews.com/lifestyle

“This inspired its scientific name, which references the fictional Japanese kaiju also known as Mothra. Only distantly related to real moths – as well as spiders, crabs, and millipedes – Mosura belongs on a much deeper branch in the evolutionary tree of these animals, collectively known as arthropods,” the statement added.

Instead of arteries and veins, Mosura’s heart pumped blood into large internal body cavities called lacunae. 

Interestingly, the fossils show details of Mosura’s internal anatomy – including its nervous system, circulatory system, and digestive tract. 

Instead of arteries and veins, Mosura’s heart pumped blood into large internal body cavities called lacunae.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

ROM curator Jean-Bernard Caron said that “few fossil sites in the world offer this level of insight into soft internal anatomy.”

Yoho National Park

Most Mosura fossils were found at Yoho National Park in British Columbia, Canada. (iStock)

“We can see traces representing bundles of nerves in the eyes that would have been involved in image processing, just like in living arthropods,” the expert added. 

CLICK HERE TO GET THE FOX NEWS APP

“The details are astounding.”

Dr. Kalifa Oliver Wins 2025 Communicator Award for Groundbreaking Audiobook “I Think I Love My Job”

0
20250519 173317233
Dr. Kalifa Oliver Wins 2025 Communicator Award for Groundbreaking Audiobook “I Think I Love My Job” 7

Celebrated Author Also Named Finalist for 2025 International Impact Book Awards Author of the Year and Quarter Finalist for 2024 Booklife Prize Ahead of Book’s First Anniversary.

GREER, SC — May 19, 2025 — Press 49 proudly announces that “I Think I Love My Job: Secrets to Designing a People-Centered Employer Value Proposition (That You Can Actually Boast About)” by Dr. Kalifa Oliver has received a prestigious 2025 Award of Distinction in the Audio Book for Audio & Voice category from The Communicator Awards. The honor recognizes excellence in audio storytelling and delivery, spotlighting a work that is redefining how leaders build inclusive and empowering workplace cultures.

This award adds to the growing list of accolades for the book, which was also recently named a quarter finalist in the 2024 Booklife Prize—a highly regarded competition celebrating outstanding independently published works. Additionally, Dr. Oliver has also been selected as a 2025 Finalist for Author of the Yearin the category of Non-Fiction – Leadership & Business Strategy by the International Impact Book Awards. The winner will be announced on October 4, 2025, at the Hollywood Grand Gala.

Released on June 21, 2024, the book is now approaching its one-year anniversary. In under twelve months, “I Think I Love My Job” has inspired professionals across industries with its sharp, candid guidance on designing a people-centered employer value proposition (EVP) that actually lives up to its promises. Blending analytics with empathy, Dr. Oliver delivers a practical blueprint for transforming employer brand into meaningful employee experience.

The book’s powerful message and engaging voice have struck a chord with a broad audience—from HR executives and DEI professionals to entrepreneurs and corporate culture champions—making this debut a standout in both content and delivery.

ABOUT THE AUTHOR

Kalifa Oliver, PhD, is an international experience coach, executive advisor, keynote speaker, author, and a respected expert in people-centered design and employee experience analytics. She is known for her ability to help companies across sectors—from scrappy startups to Fortune 500 powerhouses—transform their culture, reposition their employer value proposition, and align their brand from the inside out.

At Ford Motor Company, Dr. Oliver led the charge in the company earning the 2025 Breakthrough Award for Employee Experience Strategyat the Qualtrics X4 Conference, one of the most prestigious recognitions in the industry for innovative, people-first transformation.

She also coaches executives and emerging leaders on how to command their voice, space, and energy—guiding them to step confidently into their Main Character Season.

A native of Trinidad & Tobago, Dr. Oliver holds a PhD in Industrial-Organizational Psychology from Clemson University, a Certification in People Analytics from the Massachusetts Institute of Technology (MIT), and is a proud graduate of Benedict College, an HBCU in Columbia, South Carolina.

ABOUT PRESS 49

Press 49 is a hybrid publishing company committed to amplifying bold, transformative voices through nonfiction works that inspire, inform, and ignite change. Headquartered in Chandler, Arizona, and founded by award-winning international speaker and publisher Bridgett McGowen-Hawkins, Press 49 empowers authors to own their stories and shape their legacy.

Press 49 always looks for exciting new books and go-getters to join the company’s family of authors. 

For more information, please visit: www.press49.com

Media Contact:

Press 49
Attn: Media Relations
4980 S. Alma School Rd., #2-493
Chandler, AZ 85248
833-PRESS49 (833-773-7749)
info@press49.com

20250421 195710588
Dr. Kalifa Oliver Wins 2025 Communicator Award for Groundbreaking Audiobook “I Think I Love My Job” 8

 

Education Department rescinds record $37.7 million fine against Grand Canyon University

0

The U.S. Department of Education has rescinded a $37.7 million fine, with prejudice, against Grand Canyon University for alleged deceptive practices, according to the university.

The proposed fine was the largest ever issued by the department against a university.

University President Brian Mueller welcomed the decision to rescind the fine.

“The facts clearly support our contention that we were wrongly accused of misleading our Doctoral students, and we appreciate the recognition that those accusations were without merit,” Mueller said in a statement.

HARVARD UNIVERSITY PRESIDENT TAKES 25% PAY CUT AMID TRUMP ADMINISTRATION FUNDING FREEZE

Grand Canyon University President Brian Mueller welcomed the decision to rescind the fine. (Grand Canyon University)

“GCU is a leader in innovation, transparency and best practices in higher education and we look forward to working cooperatively with the Department in the future – just as we have with all regulatory agencies,” he continued.

The fine was imposed in October 2023 after the federal government reported that an investigation found that 78% of doctoral students who graduated between 2017 and 2022 required additional courses and incurred additional costs of at least $10,000 to complete their programs.

Education Department

The U.S. Department of Education has rescinded a $37.7 million fine, with prejudice, against Grand Canyon University. (J. David Ake/Getty Images)

The university appealed the fine the following month, with Mueller accusing the federal government of being “out of control” and targeting one of the largest Christian universities in the country, according to a statement at the time.

Mueller also said in a speech at the time that the fine was “ridiculous” and noted that another top Christian university, Liberty University, was reportedly being threatened with a $37 million fine for allegedly underreporting crimes.

TRUMP TITLE IX TEAM PROBING EDUCATION CHIEF WHO CALLED IT ‘INACCURATE’ TO SAY THERE ARE ONLY BOYS AND GIRLS

DOE

The proposed fine was the largest ever issued by the Department of Education against a university. (STEFANI REYNOLDS/AFP via Getty Images)

CLICK HERE TO GET THE FOX NEWS APP

“It’s interesting, isn’t it, that the two largest Christian universities in the country, this one and Liberty University, are both being fined almost the identical amount at almost the identical time?” he said. “Now is there a cause and effect there? I don’t know. But it’s a fact.”

The Department of Education’s move to rescind the fine ends a yearslong legal battle for the university.

Study reveals additional health perk of weight-loss medications

0

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary benefit of reducing alcohol intake.

A team of international researchers from Ireland and Saudi Arabia followed 262 adult patients with obesity who started taking two GLP-1 medications: liraglutide or semaglutide.

Among the regular drinkers, weekly alcohol intake decreased by 68%, from approximately 23 units of alcohol to around 8 units.

WEIGHT LOSS, DIABETES DRUGS CAN CAUSE MOOD CHANGES: WHAT TO KNOW ABOUT BEHAVIORAL SIDE EFFECTS

The findings were recently published in the journal Diabetes, Obesity and Metabolism and were also presented last week at the European Congress on Obesity in Spain.

GLP-1 agonists mimic a hormone called GLP-1, which is released from the gastrointestinal system after eating, according to study co-author Carel Le Roux, a professor at University College Dublin.

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists have been shown to have the surprising secondary benefit of reducing alcohol intake. (iStock)

These medications activate GLP-1 receptors in the brain, decreasing the sense of “reward” people feel after eating or drinking, eventually leading to reduced cravings for both food and alcohol, he told Fox News Digital.

“It is this commonality of function that suggests the GLP-1 receptors in the brain may be a therapeutic target for not just the disease of obesity, but also for alcohol use disorder,” the professor said.

Study findings

Before the participants started the weight-loss drugs, they self-reported their weekly alcohol intake, then were categorized as non-drinkers, rare drinkers or regular drinkers.

Approximately 72% had at least two follow-up visits and 68% reported regular alcohol consumption.

WEIGHT-LOSS DRUGS’ IMPACT ON CANCER RISK REVEALED IN NEW STUDY

After starting the weight-loss medications, the participants’ weekly average alcohol intake decreased by almost two-thirds overall — from approximately 11 units of alcohol to four units after four months of treatment with the GLP-1 agonists.

The reduction in alcohol use was comparable to the decrease that can be achieved by nalmefene, a drug that decreases the “buzz” feeling in people with alcohol use disorder in Europe, according to the researchers.

Man drinking alcohol

Among the regular drinkers, weekly alcohol intake decreased by 68%, from approximately 23 units of alcohol to around 8 units. (iStock)

For the 188 patients who were followed over an average of four months, none had increased their alcohol intake after starting the weight-loss medications.

Patients reported that after an evening meal, they were too full to have their usual drink — and when they did drink, they reported becoming full extremely quickly and drinking at a slower pace, Le Roux noted.

“The findings in this study suggest that we may have just found a therapeutic target for alcohol use disorder.”

This suggests that the experience was less enjoyable, partly due to the reduced rate of alcohol absorption.

Some patients also reported that they didn’t enjoy the flavor of the alcoholic beverages as much, and also that hangovers were much worse.

All of these experiences showed that the weight-loss medications create “guard rails” that prevent most patients from drinking excessively, giving them a degree of control over their alcohol intake, according to Le Roux.

Woman drinking wine

After starting the weight-loss medications, the participants’ weekly average alcohol intake decreased by almost two-thirds overall. (iStock)

“The findings in this study suggest that we may have just found a therapeutic target for alcohol use disorder — the GLP-1 receptor,” the professor told Fox News Digital.

“This finding potentially opens the possibility of an entirely new pharmacological treatment paradigm, which could be used in conjunction with conventional methods, such as behavior therapy and group support.”

Potential limitations

The study was limited by its relatively small number of patients, the researchers acknowledged.

Also, the researchers were not able to verify the participants’ self-reported alcohol intake, and roughly one-third of them were not available for follow-up.

SEMAGLUTIDE FOUND TO HAVE SHOCKING BENEFIT FOR LIVER DISEASE PATIENTS IN NEW STUDY

There was also no control group, which means the researchers couldn’t prove that taking weight-loss medication reduces alcohol intake.

A woman prepares to administer an insulin injection

The main advantage of GLP-1 agonists is that they only need to be taken once a week and continue to work for the entire week. (iStock)

“Randomized, controlled trials with diverse patient populations — including patients diagnosed with alcohol use disorder — are needed to provide the quality and quantity of data that could be used to support an application for licensing the medication for the treatment of alcohol use disorder,” Le Roux said.

(One such trial is currently underway in Denmark.)

Study implications

With the current medications available to treat alcohol use disorder, the “major problem” is compliance, Le Roux said — “because the cravings for alcohol tend to come in waves.”

CLICK HERE TO GET THE FOX NEWS APP

“This means a patient might be fully committed to treatment at one point in the week, but then stop taking the medication later in the week when a craving comes,” the professor added.

two wine glasses

“This research suggests a promising ancillary benefit of GLP-1 analogs, potentially influencing cravings for alcohol and offering a new avenue for managing alcohol use disorder,” a physician said. (iStock)

There are currently three FDA-approved medications to treat alcohol use disorder: naltrexone (which helps decrease cravings by reducing the “buzz” feeling that comes with drinking alcohol); disulfiram (which helps some people avoid alcohol by making them feel sick when they drink), and acamprosate (which restores the balance of hormones in the brain to reduce cravings), according to the National Institute on Alcohol Abuse and Alcoholism.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

But less than 10% of people with alcohol use disorder get the proper treatment, with many resuming use within the first year of treatment, past research shows.

The main advantage of the GLP-1 agonists is that they only need to be taken once a week and continue to work for the entire week.

Close-up of Ozempic pens and person injecting needle in background

For the 188 patients who were followed over an average of four months, none had increased their alcohol intake after starting the weight-loss medications. (iStock)

Outside experts say the study’s findings highlight the potential of weight-loss medications to help treat alcohol use disorder.

“This research suggests a promising ancillary benefit of GLP-1 analogs, potentially influencing cravings for alcohol and offering a new avenue for managing alcohol use disorder,” Dr. Fatima Cody Stanford, obesity medicine physician at Massachusetts General Hospital and Harvard Medical School, who was not part of the study, told Fox News Digital.

For more Health articles, visit www.foxnews.com/health

“While the exact mechanisms are still being explored, the findings contribute to our understanding of the broader benefits of GLP-1 analogs beyond obesity treatment,” Stanford added.

Archaeologists found sophisticated Ptolemaic and Roman era fortifications, once protected Egypt

0

Ancient military fortifications dating back to the Ptolemaic and Roman eras of Egyptian history were recently uncovered by archaeologists.

The Egyptian Ministry of Tourism and Antiquities announced the discovery in a Facebook post, which was translated from Arabic to English, on May 3. Officials said that a recent excavation at the Tell Abu Sefeh site led to the uncovering of an expansive military complex. 

The Tell Abu Sefeh site is located in North Sinai, near the Egyptian city of Ismailia and the Suez Canal.

ARCHAEOLOGISTS DISCOVER LONG-LOST TOMB OF UNKNOWN PHARAOH IN EGYPT

Described as one of Egypt’s “important strategic locations,” Tell Abu Sefeh emerged as a prominent location in antiquity. The ministry of tourism and antiquities said the site played a “pivotal role in protecting Egypt’s eastern borders.”

There, archaeologists “uncovered remains of military fortifications, soldiers’ residential units, and a trench indicating the possibility of another fortress in the area,” according to the ministry. 

An Egyptian archaeological mission recently uncovered the remains of military fortifications in the North Sinai governorate. (Egyptian Ministry of Tourism and Antiquities/Handout via Getty Images)

Aerial pictures show the sophisticated ancient military fortifications, along with artifacts such as basins and pots. 

Experts also believe that trees once lined a road to the fortress.

“[M]ore than 500 clay circles were uncovered on both sides of the stone road, likely used for planting trees that adorned the entrance of the fortress during the Ptolemaic era,” the release noted.

ARCHAEOLOGISTS UNCOVER TREASURES FROM 3,000-YEAR-OLD GOLD MINE IN EGYPT THAT ‘REVEALS HISTORICAL SECRETS’

Egyptian officials added that the soldiers’ residences “provide a clear picture of the daily life of cavalry stationed at the Roman fortress during the reigns of Emperor Diocletian and Emperor Maximian.”

“[T]he discovery of four large kilns used for producing quicklime [also indicate] the site’s transformation into an industrial center at the end of the Roman era, leading to the destruction of all stone structures at the site,” the statement added.

Aerial photo of military fortifications

The findings were made at the historical site of Tell Abu Seify, a location of strategic importance. (Egyptian Ministry of Tourism and Antiquities/Handout via Getty Images)

Archaeologists also discovered a road that was over 330 feet long and 36 feet wide. 

It was “paved with limestone slabs, extending from outside the eastern gate of the Roman fortress to the heart of the site.”

For more Lifestyle articles, visit foxnews.com/lifestyle

“[This] road is built over an older road from the Ptolemaic era, constructed from limestone slabs,” the statement said.

Egyptian Minister of Tourism and Antiquities Sherif Fathy said in a statement that the discovery “sheds light on the secrets of Egypt’s eastern military fortifications during the Ptolemaic and Roman eras.”

Wide shot of building at excavation site

The discovery offers insights into the design and function of eastern military fortifications in antiquity. (Egyptian Ministry of Tourism and Antiquities/Handout via Getty Images)

“[It also] highlights the significance of Tell Abu Sefeh as a military and industrial center throughout the ages,” the official added.

Secretary-General of the Supreme Council of Antiquities Mohamed Ismail Khaled echoed Fathy’s sentiment.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

The excavation “contributes to a more accurate depiction of the map of Egypt’s defenses on its eastern borders, reaffirming that Sinai has always been Egypt’s eastern gateway and first fortress,” he added. 

It was “paved with limestone slabs, extending from outside the eastern gate of the Roman fortress to the heart of the site.”

“[The mission also] managed to uncover a distinctive architectural design for the eastern gates of the previously discovered Ptolemaic and Roman fortresses at the site, aiding in re-imagining the shape of defensive entrances at that time, along with a massive defensive trench over two meters deep at the entrance of the Ptolemaic fortress, believed to be part of a defensive system that could be disabled when threatened,” Khaled added. 

Wide shot of building at excavation site

The discovery offers insights into the design and function of eastern military fortifications in antiquity. (Egyptian Ministry of Tourism and Antiquities/Handout via Getty Images)

The announcement comes weeks after the Egyptian Ministry of Tourism and Antiquities announced the unusual discovery of a false door at an ancient Egyptian tomb.

CLICK HERE TO GET THE FOX NEWS APP

Before that, the ministry reported another rare find: a 3,000-year-old mining complex, complete with remnants of millennia-old baths, workshops and homes.

Iran foreign minister vows nuclear enrichment continues with or without US deal

0

Iran’s foreign minister said Sunday that regardless of whether a nuclear deal is reached with the U.S., enrichment will continue.

Foreign Minister Seyed Abbas Araghchi addressed negotiations between Iran and the U.S. in a post on X regarding Iran’s “peaceful nuclear program.”

In the statement, Araghchi pointed out that U.S. officials privy to the discussions are free to state whatever they want to ward off special interest groups or malign actors that set the agendas of previous administrations.

“Iran can only control what we Iranians do, and that is to avoid negotiating in public—particularly given the current dissonance we are seeing between what our U.S. interlocutors say in public and in private, and from one week to the other,” Araghchi said. “Our stance on Iran’s rights as a [Nuclear Non-Proliferation Treaty] member is crystal clear, and there is no scenario in which Iranians will permit deviance from that. 

TRUMP SAYS US HAS GIVEN IRAN PROPOSAL FOR NUCLEAR DEAL

“Mastering enrichment technology is a hard-earned and homegrown scientific achievement; an outcome of great sacrifice of both blood and treasure,” he continued. “If the U.S. is interested in ensuring that Iran will not have nuclear weapons, a deal is within reach, and we are ready for a serious conversation to achieve a solution that will forever ensure that outcome. Enrichment in Iran, however, will continue with or without a deal.”

The statement comes just days after President Donald Trump announced on Friday that the U.S. had given Iran a proposal for a nuclear deal.

While making the announcement, Trump said Iranian officials know they have to move quickly or “something bad is going to happen.”

MARCO RUBIO WARNS IRAN ‘AT THE THRESHOLD’ OF NUCLEAR WEAPON CAPABILITY AS US-IRAN TALKS CONTINUE

Iranian Foreign Minister Abbas Araghchi, left, speaks with an unidentified Omani official upon his arrival at Muscat, Oman, Friday, April 25, 2025, a day prior to negotiations with U.S. Mideast envoy Steve Witkoff. (AP)

U.S. and Iranian officials have held four rounds of talks, primarily in Oman, since Trump took office to address Tehran’s nuclear program.

The International Atomic Energy Agency, often referred to as the United Nations’ nuclear watchdog, noted in a March report that Iran’s stockpile of 60% enriched uranium had alarmingly grown from 182 kg to 275 kg, approximately 401 pounds to 606 pounds, in early 2025.

“Once you’re at 60, you’re 90% of the way there. You are, in essence, a threshold nuclear weapons state, which is what Iran basically has become,” Rubio said Thursday on “Hannity”.

IRAN’S LONG TRAIL OF DECEPTION FUELS SKEPTICISM OVER NEW NUCLEAR DEAL AS TALKS CONTINUE

Trump and Ayatollah Khamenei examining Iranian centrifuges

Trump in a split image showing Ayatollah Khamenei examining Iranian centrifuges. (Reuters)

“They are at the threshold of a nuclear weapon. If they decided to do so, they could do so very quickly. If they stockpile enough of that 60% enriched, they could very quickly turn it into 90 and weaponize it. That’s the danger we face right now. That’s the urgency here,” he said.

The president also said Thursday in the United Arab Emirates that the U.S. and Iran have “sort of” agreed to terms on a nuclear deal.

CLICK HERE TO GET THE FOX NEWS APP 

“Iran has sort of agreed to the terms. They’re not going to make — I call it, in a friendly way — nuclear dust,” Trump told reporters. “We’re not going to be making any nuclear dust in Iran.”

Fox News Digital’s Greg Norman, Ashley Carnahan and Christina Shaw contributed to this report.

Biden’s prostate cancer is ‘pretty far advanced,’ medical expert says

0

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%.

The former president’s prostate cancer is characterized by a Gleason score of 9 and Grade Group 5 with bone metastasis, indicating that it is “pretty far advanced,” Fox News senior medical analyst Dr. Marc Siegel said on ‘Fox Report.’

“It’s the most aggressive type,” Siegel said. “That means it has the highest risk of spread — which obviously he has had.”

Biden is also presenting with urinary symptoms, which is another sign that the cancer is advanced. Prostate cancer often presents as asymptomatic in its early stages, he said. 

JOE BIDEN DIAGNOSED WITH ‘AGGRESSIVE FORM’ OF PROSTATE CANCER WITH METASTASIS TO THE BONE

President Biden’s cancer is “pretty far advanced,” according to Dr. Marc Siegel. (SAUL LOEB/AFP via Getty Images)

“This was found by physical examination by a prostate exam,” Siegel said. “A lot of times we find an elevation in prostate-specific antigen, PSA, and then we go after it… I mean, he must have had the best possible care here. I’m a little taken aback that it’s this far advanced.”

Siegel said he conducts a prostate-specific antigen, or PSA, test on every male over the age of 45 years old. The test measures how much PSA is in the blood and is primarily used to screen for prostate cancer, according to Mayo Clinic

NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDS

While the PSA test is not always a perfect indicator of prostate cancer, someone who has a rise in PSA automatically gets an MRI, Siegel said. After the MRI, a decision is made about whether to conduct a biopsy.

More than 80% of men over the age of 80 years old have some prostate cancer cells in their body, according to Siegel.

“It would be really surprising if they weren’t doing a very close screening on this because everybody knows in the medical community that this is the one cancer in men you really look out for,” he said. “… He doesn’t seem to have a lot of risk factors that I would think about other than age, but age is enough and he’s 82, so that’s a big risk factor.”

Doctors will likely treat Biden with hormone therapy, Siegel said. They may also attempt to radiate the lesion found on the bone or remove the prostate altogether.

PROSTATE CANCER DRUG NOW AVAILABLE TO MORE PATIENTS WITH AGGRESSIVE FORM OF DISEASE

“Sometimes they decide to do more than one therapy,” Siegel said. “They might try to take the prostate out, do radiation and the hormone therapy altogether. That’s not uncommon.”

There are two types of medications used to treat this type of advanced prostate cancer — Lupron, which stops testosterone production, and Casodex, which stops testosterone from binding. Side effects of the medication can leave people feeling “fatigued and listless,” according to Siegel.

PSA testing (prostate cancer diagnosis) by using test cassette, the result showed positive (double red line)

The PSA test measures how much PSA is in the blood and is primarily used to screen for prostate cancer. (iStock)

“The other thing I’m concerned about is bone pain, because those metastases to the bone can be pretty painful,” he said.

If the cancer is caught early while its still localized to the prostate gland, it’s curable “most of the time,” Siegel said.

CLICK HERE TO GET THE FOX NEWS APP

The goal is to get it before it leaves the prostate,” Siegel said. “When it’s left the prostate, it becomes much more difficult to cure.”

Biden’s prostate cancer labeled ‘aggressive’ — what that means for prognosis and treatment

0

Prostate cancer cases have been on the rise in recent years, increasing 3% annually since 2014 – and now former President Joe Biden is one of the more than 300,000 men to be diagnosed this year.

Biden’s office released the announcement on Sunday, days after news that a “small nodule” had been found in the former president’s prostate during a routine exam

“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive, which allows for effective management,” his office said. “The president and his family are reviewing treatment options with his physicians.”

NEW PROSTATE CANCER TEST PINPOINTS DISEASE BETTER THAN PSA OPTION, STUDY FINDS

Treatment is usually more effective when prostate cancer is hormone-sensitive, as that means the disease will likely respond better to hormone therapy, according to Mayo Clinic.

Hormone therapy is used to block the effects of the hormones that fuel the growth of prostate cancer cells.

Former President Joe Biden is one of the more than 300,000 people to be diagnosed with prostate cancer this year. (Getty Images)

“Prostate cancer cells rely on testosterone to help them grow. Cutting off the supply of testosterone may cause cancer cells to die or to grow more slowly,” the above source stated.

In addition to hormone therapy, common treatment options for prostate cancer include chemotherapy, targeted therapy, immunotherapy and radiopharmaceutical treatments.

What to know about prostate cancer

Prostate cancer is a disease found in men that develops in the prostate gland. 

About 313,780 new cases of prostate cancer will be diagnosed in 2025, and 35,770 men will die from the disease, according to the American Cancer Society.

Hormone therapy is used to block the effects of the hormones that fuel the growth of prostate cancer cells.

One in eight men will be diagnosed with prostate cancer in their lifetime, the same source stated.

Older men are at a higher risk of the disease, with six in 10 cases diagnosed in patients 65 and older. The average age at diagnosis is 67, with men under 40 rarely affected. Biden is 82.

PROSTATE CANCER DRUG NOW AVAILABLE TO MORE PATIENTS WITH AGGRESSIVE FORM OF DISEASE

Prostate cancer is the second-most common cancer in men, behind only skin cancer, the ACS noted.

Signs and symptoms

Among men who undergo routine prostate cancer screening, the disease is usually caught early before symptoms emerge, per the ACS.

Typical early symptoms include problems urinating, a weak or slow urinary stream or an increased need to urinate.

Medical tech prostate

About 313,780 new cases of prostate cancer will be diagnosed in 2025 and 35,770 men will die from the disease, according to the American Cancer Society. (iStock)

Some men may also notice blood in the urine or bodily fluids.

More advanced symptoms may occur after the disease has spread. Those may include pain in the hips, back (spine), chest (ribs) or other areas, the ACS stated.

CLICK HERE TO GET THE FOX NEWS APP

Men may also suffer from erectile dysfunction, weight loss, extreme fatigue, weakness in the legs or feet, or loss of bladder or bowel control.

Screening recommendations

The U.S. Preventive Services Task Force states that men aged 55 to 69 years should have the option to undergo periodic prostate-specific antigen (PSA)-based screening to monitor for prostate cancer

“Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision,” the USPSTF states. 

PSA testing (prostate cancer diagnosis) by using test cassette, the result showed positive (double red line)

While screening offers a “small potential benefit” of reducing the chances of dying from the disease, health officials warn that some men may experience negative effects. (iStock)

While screening offers a “small potential benefit” of reducing the chances of dying from the disease, the agency noted that some men may experience negative effects, including false-positive results, overdiagnosis and overtreatment, and treatment complications.

Alternative prostate cancer screening methods are currently being researched, including one that uses a non-invasive urine test, as Fox News Digital recently reported.

Survival rates

For localized prostate cancers, where the disease is contained within the prostate, the five-year survival rate is at least 99%, according to the ACS.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

For regional cases, where the disease has spread only to “nearby structures or lymph nodes,” the five-year survival rate is also 99% or greater.

For more Health articles, visit www.foxnews.com/health

If the cancer has spread to other areas of the body, the five-year survival rate drops to 37%.

Actual survival rates may vary based on the patient’s age, overall health, how the cancer has progressed post-diagnosis, the disease’s response to treatment, and other factors, the ACS noted.

Airline banned family from flight over bug bites despite medical assurances

0

A family was banned from boarding their flight after British Airways staff became suspicious of insect bites on their baby’s leg, according to a report from SWNS.

Expat Jonathan Arthur, 34, and his wife Xun Sun, 35, were flying from Shanghai Pudong Airport to London Heathrow for a family wedding. 

They noticed some insect bites on their 1-year-old son Joseph’s leg as they approached the boarding gate and asked airline staff where they could buy some allergy medication, just in case.

FLESH-EATING NEW WORLD SCREWWORM COULD POSE HEALTH RISKS TO CATTLE, HUMANS

When the staff at the boarding gate saw the bites and heard the family talking about allergy medication, they became concerned, the report stated.

“They asked loads of questions after they saw the bites, and so we told them about his mild peanut allergy,” said Jonathan Arthur. “The medical staff at the airport said to apply some ointment and wait 10 minutes, which we were happy to do. But the BA staff said we needed to call their medical advice line. They thought his peanut allergy was the cause — so they didn’t want to take the risk.”

A family was banned from boarding their flight after British Airways staff became suspicious of insect bites on their baby’s leg. (iStock)

The family also sent photos to an online doctor, who confirmed they were insect bites but recommended administering some antihistamines to help with the swelling.

The baby’s bites were no larger than 1 cm in diameter and disappeared within 10 to 15 minutes after applying the bite cream, causing him no further discomfort, as stated by SWNS.

PREGNANT WOMAN AND BABY SAVED AFTER DOCTORS FIND GRAPEFRUIT-SIZED TUMOR: ‘EXTREMELY RARE’

“It was nothing more than swollen bites,” said Jonathan Arthur.

Baby's forearm (zoomed in) showing rash along forearm, bug bites

The baby’s bites were no larger than 1 cm in diameter and disappeared within 10 to 15 minutes after applying the bite cream, causing him no further discomfort, per the report. (SWNS)

Despite the fact that the baby’s bites were already starting to subside, the airline said the family wouldn’t be allowed to board without a “fit to fly” letter from a doctor.

The Arthurs were escorted away from the gate, “feeling like criminals,” according to the SWNS report. They rebooked with another airline that did not require a medical letter.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“We were treated like we had done something wrong,” said Jonathan Arthur, per the SWNS report.

CLICK HERE TO GET THE FOX NEWS APP

In a statement to Fox News Digital, British Airways stated, “We take the safety and well-being of our customers very seriously and do everything we can to support them when issues like this arise. This includes accessing specialist medical advice to assess an individual’s suitability to travel, which is what happened in this case.”

“Whilst we appreciate our customer was disappointed with this decision, we never compromise passenger safety.”

split image, one side shows man and wife sat on their flight with a flight attendant in the background. The mother is holding her baby in her lap (face of baby blurred) as her and her husband look into the camera. The other side shows one of the parents holding their baby's right arm up to show bug bites on the forearm and hand. The baby's face is blurred as well

Despite the family’s assurances that the rash was unrelated to allergy, the airline insisted they wouldn’t be allowed to board without a “fit to fly” letter from a doctor. (SWNS)

Jonathan and Xun Arthur are now in contact with British Airways and their third-party booking agency to claim a refund for the disrupted travel

For more Health articles, visit www.foxnews.com/health

“I find it strange that someone else in a different country can speak to an airport staff member who isn’t a medical professional, and diagnose and refuse boarding, without seeing the rash,” Jonathan Arthur added. 

“When you pay for a service, you expect to be treated like a customer, not like a hindrance.”

Brown line on fingernail helped catch cancer early, thanks to TikTok video

0

A TikTok video played a key role in one mother’s cancer diagnosis after it prompted her to see a doctor regarding a strange marking on her fingernail, SWNS reported.

Lauren Koltcz, 45, from North Royalton, Ohio, noticed a brown line on her left thumbnail, but thought it was caused by a vitamin deficiency.

“I had this nagging feeling it was something more than a vitamin deficiency,” she said.

4 TROUBLING CANCER TRENDS YOU MUST KNOW ABOUT IN 2025

When the brown line became thicker, the mother of two spoke to her nurse practitioner, who said it could be a fungal infection.

“I put some fungal medication on my thumb, but it didn’t do anything,” she said, as SWNS reported.

Lauren Koltcz, 45, from North Royalton, Ohio, noticed a brown line on her left thumbnail, but thought it was caused by a vitamin deficiency. (SWNS)

Then, in February 2025, Koltcz noticed the line spreading across her nail.

“I started researching online and found some TikTok videos from dermatologists,” she recalled.

RARE SPINAL CANCER TUMOR REMOVED THROUGH PATIENT’S EYE AT UNIVERSITY HOSPITAL

In one video, a dermatologist implored those with brown lines on their nails to see a medical professional.

Koltcz booked an appointment at Cleveland Clinic, where doctors took a biopsy of the brown area.

“I had this nagging feeling it was something more than a vitamin deficiency.”

The next day, she got a call from her doctor, Alison Vidimos, MD, who said they needed to do a biopsy.

“I was concerned because the pigmentation on her nail was very dark, there were different shades of brown, and the spot was wider than 3 millimeters,” said Vidimos, who is chairman emeritus of Cleveland Clinic’s Department of Dermatology.

TERMINAL COLON CANCER PATIENT SAVED BY BREAKTHROUGH TREATMENT

The biopsy results came back four days later.

“I just couldn’t believe it. Everybody knows someone who’s had cancer, and now I was one of them,” Koltcz said.

Lauren Koltcz, 45, from North Royalton, Ohio, noticed a brown line on her left thumbnail, but thought it was caused by a vitamin deficiency.

Koltcz, pictured here, was diagnosed with subungual melanoma, a skin cancer that develops under the nail. (SWNS)

The results showed that Koltcz had subungual melanoma – a skin cancer that develops under the nail – but they had caught it at stage 0, meaning the melanoma was only in the top layer of the skin.

Subungual melanoma (nail melanoma) is a serious and rare type of skin cancer, accounting for 0.7% to 3.5% of all melanomas worldwide, according to Cleveland Clinic.

For more Health articles, visit www.foxnews.com/health

It can impact any nail and discoloration doesn’t always occur, which is why it’s so important to take note of any nail changes.

“When this type of cancer is caught early, there’s over a 95% survival rate,” Vidimos said in a press release from Cleveland Clinic. “But if it’s neglected and not diagnosed at an early stage, it can spread to the lymph nodes and make treatment more challenging.”

Lauren Koltcz's brown line on her left thumbnail.

Koltcz watched a TikTok video from a dermatologist warning that brown lines on the nail should be checked by a doctor. (SWNS)

Nail melanomas are often diagnosed late, according to the doctor, because people don’t think about checking their nails.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Prompt surgery removed Koltcz’s cancer and some of the tissue around the area to ensure that no cancer cells remained.

“I just kept thinking, ‘How lucky am I that I caught it in time and had such great doctors to treat it?'”

While she currently shows no evidence of cancer, Koltcz will have regular follow-ups with her dermatologist.

CLICK HERE TO GET THE FOX NEWS APP

“I just kept thinking, ‘How lucky am I that I caught it in time and had such great doctors to treat it?'”